DRIEHAUS CAPITAL MANAGEMENT INC 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-10-13 1:29 pm Sale |
2022-10-04 | 13G | Calidi Biotherapeutics, Inc. CLDI |
DRIEHAUS CAPITAL MANAGEMENT INC | 20,000 4.840% |
-80,000 (-80.00%) |
Filing |
| 2022-10-11 08:55 am Sale |
2022-09-30 | 13G | Calidi Biotherapeutics, Inc. CLDI |
DRIEHAUS CAPITAL MANAGEMENT INC | 100,000 24.220% |
-50,000 (-33.33%) |
Filing |
| 2022-02-14 09:28 am Purchase |
2021-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI |
DRIEHAUS CAPITAL MANAGEMENT INC | 150,000 5.220% |
150,000 (New Position) |
Filing |